<DOC>
	<DOCNO>NCT01356355</DOCNO>
	<brief_summary>The purpose study compare efficacy safety Ayurvedic formulation , Herbmed Plus placebo anti-cholinergic drug relieve ureteral stent discomfort .</brief_summary>
	<brief_title>Study Herbmed Plus Ureteral Stent Discomfort</brief_title>
	<detailed_description>- To evaluate tolerability ayurvedic preparation , Herbmed Plus management ureteral stent discomfort - To know whether ayurvedic preparation Herbmed Plus , reduce requirement analgesic - To know whether ayurvedic preparation , Herbmed Plus replace use analgesics/ anti cholinergics relieve ureteral stent discomfort ?</detailed_description>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>The following patient would enrol study : 1 . Age 1875 year ( Both inclusive ) 2 . Absence urinary tract infection 3 . Absence low urinary tract symptom 4 . Absence urethral catheter 5 . Patients unilateral/bilateral ureteral stentSize stent range 4/16 6/26 . 6 . Patients reproductive potential ( male female ) willing use reliable mean contraception ( e.g . hormonal contraceptive patch , intrauterine device physical barrier ) throughout study participation . 7Able willing give write informed consent comply requirement study protocol 1 . Patients evidence urinary tract infection . 2 . Chronic medication Î±blockers anticholinergic severe complication procedure 3 . Uncontrolled diabetes , hypertension , symptomatic congestive heart failure , unstable angina pectoris , myocardial infarction . 4 . Any urogenital disorder . 5 . Liver dysfunction , define total bilirubin &gt; 1.5 x upper limit Normal ( ULN ) , Aspartate aminotransferase ( AST/SGOT ) &gt; 2.5 x ULN , alanine aminotransferase ( ALT/SGPT ) &gt; 2.5 x ULN . 6 . Kidney disease , include serum creatinine level &gt; 1.5 x ULN . 7 . Subjects herbal supplement ( plant extract preparation herbal medicine etc . ) within previous 3 month . 8 . Participated another clinical drug trial within 3 month recruitment . 9 . Pregnancy breast feed . 10 . Evidence significant uncontrolled concomitant disease Investigator 's opinion would preclude patient participation . 11 . Currently active alcohol drug abuse history alcohol drug abuse within 24 week prior baseline . 12 . Patients psychiatric illness condition would limit compliance study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Stent discomfort</keyword>
	<keyword>Herbmed plus</keyword>
	<keyword>Tolterodine</keyword>
</DOC>